Tandem Diabetes Care, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Tandem Diabetes Care, Inc. (TNDM) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $340.00 million as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2021-02-24
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $340.00M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $248.70M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $352.70M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $335.30M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2020-12-31 | $340.00M 10-K · filed 2021-02-24 |
| 2019-12-31 | $248.70M 10-K · filed 2020-02-24 |
| 2018-12-31 | $352.70M 10-K · filed 2019-02-26 |
| 2017-12-31 | $335.30M 10-K · filed 2018-03-01 |
| 2016-12-31 | $283.50M 10-K · filed 2017-03-08 |
| 2015-12-31 | $226.30M 10-K · filed 2016-02-24 |
| 2014-12-31 | $177.20M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |